Biotech News
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
investors.polypid.com2026-05-06 15:28 EST
The Company is in Advanced Stage s of Commercial U.S. Partner ship Discussions for D-PLEX₁₀₀ Positive FDA Pre-NDA Feedback Supports Rolling NDA Review; Submission Expected to Begin by the E nd of the First Quarter of 2026 Conference Call Scheduled for Today at 8:30 AM ET PETACH TIKVA, Israel,